A pitch
ZOE
An Engine of Agential Biology
The following introduces proprietary and / or preliminary data that is not publicly available and should not be distributed without express permission.
Meet xenobots: the world’s first computer-designed living organisms.
Invented in 2020, xenobots are extraordinary because we can program fully biological robots.
Made from humble frog cells, xenobots are almost infinitely malleable.
Co-designed with artificial intelligence, xenobots are almost infinitely functional.
We call xenobots an agential biology because they harness the raw power of life:
They act with purpose.
They sense and navigate their environments.
They heal themselves.
They repair other cells.
They regenerate.
They remember.
Xenobots give us something totally new:
the ability to program life beyond the genetic code.
What CRISPR technologies have done for genetics, agential biology technologies could do for cells.
Where conventional systems fail, xenobots invent, explore, discover.
Where genetic engineering is limited to coding narrow traits, agential biology rewrites entire organisms.
Not only do agential biologies hold enormous potential to transform all areas of research and industry
But the very idea of life itself.
ZOE is a new company founded in 2026 as the premier engine of this emerging field.
ZOE will incubate transformative technologies to capitalize on agential biologies for commercial uses in industries such as pharma, medicine, beauty, and agriculture.
We are writing the next chapter in the book of life.